THERAPEUTIC AREA
saveCardiology
Diseases of the heart and cardiovascular system.
also known as: cardiovascular, cardio, cv, heart
🐶 often sniffed alongside
top 8- tagAdCom616 co-mentions · 607 sources
- tag510(k) Clearance572 co-mentions · 566 sources
- tagRecall165 co-mentions · 45 sources
- tagHematology110 co-mentions · 65 sources
- tagHeart Failure57 co-mentions · 18 sources
- tagUrology53 co-mentions · 3 sources
- tagEndocrinology & Metabolism52 co-mentions · 7 sources
- tagPMA Approval44 co-mentions · 41 sources
drugs
425
catalysts
37
news
2,860
companies
317
Top drugs
view all →Marketed
ALDACTAZIDE
Hepatic Edema
$PFE · 145 catalysts
Marketedadrenaline
Hypotension
113 catalysts
MarketedVALPROIC ACID
Pulmonary Arterial Hypertension
81 catalysts
Marketedtocilizumab
Coronavirus Disease 2019 (COVID-19)
61 catalysts
MarketedHEPARIN SODIUM
$PFE · 53 catalysts
MarketedLaryng-O-Jet
Local Anesthetic Effect
50 catalysts
MarketedGLYCOPYRROLATE
Anesthetic Effect
48 catalysts
Marketedmethylprednisolone sodium succinate
Drug Hypersensitivity Reactions
48 catalysts
🐶 Top companies
view all →Recent catalysts
view all →Apr 30, 2026
phase 2 completion
Dutch Heart Foundation — ghrelin (Phase II Trial Completion)
ghrelin
→
Apr 30, 2026
phase 2 completion
Curtin University — influenza vaccine (Phase II Trial Completion)
influenza vaccine
→
Apr 30, 2026
phase 2 completion
National Institutes of Health — metformin hydrochloride ER (Phase II Trial Completion)
metformin hydrochloride ER
→
Apr 30, 2026
phase 2 completion
Sohag University — ephedrine (Phase II Trial Completion)
ephedrine
→
Apr 30, 2026
phase 2 completion
Neurodawn Pharmaceutical Co Ltd — Loberamisal (Phase II Trial Completion)
Loberamisal
→
Apr 30, 2026
phase 2 completion
Medical University of Gdansk — apixaban (Phase II Trial Completion)
apixaban ODT
→
Apr 30, 2026
phase 2 completion
Cancer Institute and Hospital Chinese Academy of Medical Sciences — lenvatinib (Phase II Trial Completion)
lenvatinib
→
Apr 30, 2026
phase 2 completion
Medanta - The Medicity — centhaquine citrate (Phase II Trial Completion)
centhaquine citrate
→
Apr 30, 2026
phase 2 completion
German Sport University Cologne — polyphenol-rich cocoa extract (Phase II Trial Completion)
polyphenol-rich cocoa extract
→
Apr 30, 2026
phase 1 2 completion
Implicit Bioscience Ltd — Atibuclimab (Phase I/II Trial Completion)
Atibuclimab
→
Recent news
view all →- Novartis projects slowed growth, pins hopes on billions in pipeline potentialbiospace · 6h ago
- nChroma halves workforce, BioXcel lets execs gobiospace · 7h ago
- STAT+: In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatmentstat · 11h ago
- Opinion: STAT+: I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statinsstat · 13h ago
- Novartis CEO argues shareholders ‘happy overall’ with strategy, calls for COINS Act adjustmentfiercebiotech · 18h ago
- STAT+: Influential preventive services panel to meet for first time in more than a yearstat · 1d ago
- CTAD 2026: BMS’ Cobenfy eases Alzheimer’s psychosis as expected but safety events raise questionsbiospace · 1d ago
- Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concernsbiospace · 1d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that